Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

The new $3 billion manufacturing facility will be sited at the Leiden Bio Science Park in Katwijk, and will be Lilly's first ...

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

Lilly, an Indianapolis-based drugmaker, plans to build a $3 billion manufacturing plant in the Netherlands to boost ...

Increased our 2025 full-year revenue guidance to be in the range of $63.0 billion to $63.5 billion; reported EPS guidance raised to be in the range of $21.80 to $22.50 and non-GAAP EPS guidance raised ...

US-based medicine company Eli Lilly to invest $3B in a new manufacturing facility in the Netherlands to expand production and create jobs.

The 2025-26 National FFA Officer Team was elected during the final session of the 98th National FFA Convention & Expo in ...

Claire Woeppel becomes the first Nebraskan to hold a national FFA office since Brennan Costello served as Central Region Vice ...

Indiana philanthropic organizations and an anonymous donor have pooled $1 million to launch a food aid fund, the United Way ...

From meatballs to stir fries, casseroles to soups and stews, it's time to meet our best-rated, most-loved ground beef recipes ...

Indianapolis-based Eli Lilly and Company announced Monday, Nov. 3 that it plans to build a new $3 billion manufacturing ...